Interplay Between Klotho and IL-6 in Diabetic Kidney Disease: Inflammation, Mineral Dysregulation, and Renal Dysfunction

IF 0.4 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Mustafa A. Mahdi,  Dhifaf Z. Aziz
{"title":"Interplay Between Klotho and IL-6 in Diabetic Kidney Disease: Inflammation, Mineral Dysregulation, and Renal Dysfunction","authors":"Mustafa A. Mahdi,&nbsp; Dhifaf Z. Aziz","doi":"10.1134/S1990750825600396","DOIUrl":null,"url":null,"abstract":"<p>Diabetic kidney disease is a serious complication of diabetes mellitus, often leading to chronic kidney disease and ultimately end-stage renal disease. Inflammation, besides deranged mineral metabolism, plays a role in the pathophysiology of diabetic kidney disease. The present study investigated the relationship between IL-6 an important pro-inflammatory cytokine, and Klotho an anti-aging protein with renoprotective function in diabetic kidney disease progression. A study was carried out on 60 patients with ESRD caused by diabetic kidney disease on maintenance hemodialysis and 40 apparently healthy control individuals. IL-6 and Klotho serum levels were measured using the enzyme-linked immunosorbent assay method. Some biochemical indicators, such as intact parathyroid hormone, 1.25-dihydroxyvitamin D<sub>3</sub>, blood urea, and creatinine, were also measured. The main findings (mean ± SE) showed that the levels of IL-6 and iPTH levels were considerably higher in DKD patients (18.360 ± 2.323 pg/mL; 239.222 ± 24.073 pg/dL) than in controls (4.341 ± 0.393 pg/mL; 26.077 ± 1.609 pg/dL), indicating persistent inflammation and secondary hyperparathyroidism. Conversely, serum 1.25(OH)<sub>2</sub>D<sub>3</sub> and Klotho levels were considerably lower in the DKD group (14.911 ± 0.991 ng/dL and 213.500 ± 25.905 pg/mL, respectively) than in controls (29.125 ± 1.195 ng/dL and 453.587 ± 33.797 pg/mL), indicating kidney function impairment and mineral metabolism disturbance. There was a notable weak inverse relationship between IL-6 and Klotho (<i>r</i> = –0.271, <i>p</i> = 0.036). This suggests that Klotho low levels may increase inflammatory responses and adversely affect renal function. In conclusion, the research demonstrates how IL-6 and Klotho affect one another in diabetic kidney disease. This suggests their application as potential biomarkers for disease progression and targets for therapy in preventing inflammation and maintaining kidney function.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"20 2","pages":"196 - 210"},"PeriodicalIF":0.4000,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","FirstCategoryId":"2","ListUrlMain":"https://link.springer.com/article/10.1134/S1990750825600396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Diabetic kidney disease is a serious complication of diabetes mellitus, often leading to chronic kidney disease and ultimately end-stage renal disease. Inflammation, besides deranged mineral metabolism, plays a role in the pathophysiology of diabetic kidney disease. The present study investigated the relationship between IL-6 an important pro-inflammatory cytokine, and Klotho an anti-aging protein with renoprotective function in diabetic kidney disease progression. A study was carried out on 60 patients with ESRD caused by diabetic kidney disease on maintenance hemodialysis and 40 apparently healthy control individuals. IL-6 and Klotho serum levels were measured using the enzyme-linked immunosorbent assay method. Some biochemical indicators, such as intact parathyroid hormone, 1.25-dihydroxyvitamin D3, blood urea, and creatinine, were also measured. The main findings (mean ± SE) showed that the levels of IL-6 and iPTH levels were considerably higher in DKD patients (18.360 ± 2.323 pg/mL; 239.222 ± 24.073 pg/dL) than in controls (4.341 ± 0.393 pg/mL; 26.077 ± 1.609 pg/dL), indicating persistent inflammation and secondary hyperparathyroidism. Conversely, serum 1.25(OH)2D3 and Klotho levels were considerably lower in the DKD group (14.911 ± 0.991 ng/dL and 213.500 ± 25.905 pg/mL, respectively) than in controls (29.125 ± 1.195 ng/dL and 453.587 ± 33.797 pg/mL), indicating kidney function impairment and mineral metabolism disturbance. There was a notable weak inverse relationship between IL-6 and Klotho (r = –0.271, p = 0.036). This suggests that Klotho low levels may increase inflammatory responses and adversely affect renal function. In conclusion, the research demonstrates how IL-6 and Klotho affect one another in diabetic kidney disease. This suggests their application as potential biomarkers for disease progression and targets for therapy in preventing inflammation and maintaining kidney function.

Klotho和IL-6在糖尿病肾病中的相互作用:炎症、矿物质失调和肾功能障碍
糖尿病肾病是糖尿病的一种严重并发症,常导致慢性肾脏疾病,最终导致终末期肾脏疾病。除了矿物质代谢紊乱外,炎症在糖尿病肾病的病理生理中也起作用。本研究探讨了IL-6(一种重要的促炎细胞因子)和Klotho(一种具有肾保护功能的抗衰老蛋白)在糖尿病肾病进展中的关系。对60例维持血液透析的糖尿病肾病ESRD患者和40例表面健康对照进行了研究。采用酶联免疫吸附法测定血清IL-6和Klotho水平。同时测定一些生化指标,如完整甲状旁腺激素、1.25-二羟维生素D3、血尿素和肌酐。主要发现(意味着±SE)表明,il - 6的水平和iPTH DKD患者的水平相当高(18.360 ±2.323  pg / mL; 239.222±24.073  pg / dL)比在控制( 4.341±0.393  pg / mL; 26.077±1.609  pg / dL),表明持续的炎症和继发性甲状旁腺功能亢进。相反,血清1.25 (OH) 2 d3和克罗索DKD组水平要低得多(14.911 ±0.991   毫微克/分升和213.500±25.905  pg / mL,分别)比在控制(29.125 ±1.195   毫微克/分升和453.587±33.797  pg / mL),说明肾功能障碍和矿物质代谢紊乱。IL-6与Klotho呈显著的弱负相关(r = -0.271, p = 0.036)。这表明Klotho低水平可能会增加炎症反应并对肾功能产生不利影响。总之,该研究证明了IL-6和Klotho在糖尿病肾病中是如何相互影响的。这表明它们可以作为疾病进展的潜在生物标志物和预防炎症和维持肾功能的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
31
期刊介绍: Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry   covers all major aspects of biomedical chemistry and related areas, including proteomics and molecular biology of (patho)physiological processes, biochemistry, neurochemistry, immunochemistry and clinical chemistry, bioinformatics, gene therapy, drug design and delivery, biochemical pharmacology, introduction and advertisement of new (biochemical) methods into experimental and clinical medicine. The journal also publishes review articles. All issues of the journal usually contain solicited reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书